No Data
Hong Kong stock market movement | CANSINOBIO (06185) surged over 10% during trading, with the market share of Mankai steadily increasing, and first-quarter revenue rose by 20% year-on-year.
CANSINOBIO (06185) rose more than 10% during the day. As of the time of reporting, it has increased by 9.38%, reaching HKD 33.25, with a transaction volume of HKD 48.451 million.
CANSINOBIO (06185.HK) will release Earnings Reports on April 30.
$CANSINOBIO (06185.HK)$ will release its Earnings Reports on April 30th, and investors are advised to pay attention. How were the previous results? Q1 2024 revenue was 0.114 billion yuan, net income was -0.175 billion yuan, and EPS was -0.69 yuan. Futubull reminder: 1. There are no strict regulations on the fiscal year division for companies listed on the Hong Kong and American stock markets; it is entirely decided by the company itself. Therefore, each earnings report period can serve as the cutoff date for the company's annual report, rather than following the natural year as the fiscal year. 2. Generally, the company will hold an earnings meeting on or around the above earnings report release date, and company management...
Cansino: First Quarter Report 2025
2025 First Quarter Report
Express News | CanSino Biologics Inc - Qtrly Operating Revenue RMB137.2 Mln
CANSINOBIO: FIRST QUARTERLY REPORT FOR THE THREE MONTHS ENDED MARCH 31, 2025
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}